Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT02914522

Public ClinicalTrials.gov record NCT02914522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this study are to evaluate the efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or met protocol specified efficacy discontinuation criteria will have the option to enter a separate, long-term extension (LTE) study (Gilead Study GS-US-418-3899: NCT02914535).

Study identification

NCT ID
NCT02914522
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
1,351 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 14, 2016 (Actual)
Primary completion
Mar 31, 2020 (Actual)
Completion
Mar 31, 2020 (Actual)
Last update posted
Apr 21, 2021

2016 – 2020

United States locations

U.S. sites
61
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Digestive Health Specialists of the Southeast Dothan Alabama 36305 —
Mayo Clinic Arizona Scottsdale Arizona 85259 —
VA Long Beach Healthcare System Long Beach California 90822 —
Cedars Sinai Medical Center Los Angeles California 90048 —
South Denver Gastroenterology, PC Lone Tree Colorado 80124 —
Connecticut GI PC-Research Division Farmington Connecticut 06032 —
UF Health at Shands Hospital Gainesville Florida 32610 —
Florida Research Institute Lakewood Rch Florida 34211 —
University of Miami Crohn's and Colitis Center Miami Florida 33136 —
Cordova Research Institute Miami Florida 33155 —
Gastroenterology Group of Naples Naples Florida 34102 —
Advanced Medical Research Center Port Orange Florida 32127 —
Tampa General Hospital Tampa Florida 33606 —
Shafran Gastroenterology Center Winter Park Florida 32789 —
Florida Medical Clinic, P.A. Zephyrhills Florida 33540 —
Gastroenterology Associates of Central Georgia, LLC Macon Georgia 31201 —
Gastrointestinal Specialists of Georgia Marietta Georgia 30060 —
Atlanta Gastroenterology Specialist, PC Suwanee Georgia 30024 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
University of Louisville, Clinical Trials Unit Louisville Kentucky 40202 —
Delta Research Partners, LLC Monroe Louisiana 71201 —
Louisiana Research Center, LLC Shreveport Louisiana 71105 —
Investigative Clinical Research Annapolis Maryland 21401 —
MGG Group Co., Inc., Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Gastro Center of Maryland Columbia Maryland 21045 —
Meritus Center for Clinical Research Hagerstown Maryland 21742 —
Massachusetts General Hospital - Crohn's and Colitis Center Boston Massachusetts 02114 —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047 —
Center for Digestive Health Troy Michigan 48098 —
Mayo Clinic Rochester Minnesota 55905 —
Kansas City Research Institute Kansas City Missouri 64131 —
Washington University School of Medicine St Louis Missouri 63110 —
NY Scientific Brooklyn New York 11235 —
NYU Langone Long Island Clinical Research Associates Great Neck New York 11021 —
Carolina's GI Research, LLC Raleigh North Carolina 27607 —
Fargo Gastroenterology and Hepatology Clinic Fargo North Dakota 58103 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
UC Health Physicians Clifton Cincinnati Ohio 45219 —
Great Lakes Gastroenterology Research, LLC Mentor Ohio 44060 —
Gastroenterology Associates of Orangeburg Orangeburg South Carolina 29118 —
Rapid City Medical Center Rapid City South Dakota 57701 —
WR-ClinSearch, LLC Chattanooga Tennessee 37421 —
Gastro One Germantown Tennessee 38138 —
Quality Medical Research Nashville Tennessee 37211 —
Vanderbilt University Medical Center - IBD Clinic Nashville Tennessee 37212-1375 —
San Antonio Military Medical Center Fort Sam Houston Texas 78219 —
DHAT Research Institute Garland Texas 75044 —
Baylor College of Medicine- Baylor Medical Center Houston Texas 77030 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
Clinical Associates in Research Therapeutics of America, LLC San Antonio Texas 78212 —
Gastroenterology Research of San Antonio San Antonio Texas 78229 —
Texas Digestive Disease Consultants San Marcos Texas 78666 —
Texas Digestive Disease Consultants Southlake Texas 76092 —
Spring Gastroenterology The Woodlands Texas 77380 —
HP Clinical Research Bountiful Utah 84010 —
University of Virginia Health System Charlottesville Virginia 22908 —
Gastroenterology Associates Of Tidewater Chesapeake Virginia 23320 —
Emeritas Research Group LLC Lansdowne Town Center Virginia 20176 —
McGuire DVAMC Richmond Virginia 23249 —
University of Wisconsin Hospital & Clinics Madison Wisconsin 53705 —
Allegiance Research Specialists, LLC Wauwatosa Wisconsin 53225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 282 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02914522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2021 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02914522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →